How SGLT2-I and and Angiotensin receptor blockers together affect Diabetic kidney disease
Not Applicable
- Conditions
- Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications
- Registration Number
- CTRI/2022/05/042657
- Lead Sponsor
- Thakurpukur Medical Society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed case of Diabetic Kidney Disease
Type 2 Diabetes Mellitus with
a. Urinary Spot ACR > 30 mg/g
and / or
b. eGFR, calculated by CKD-EPI < 90 mL/min/1.73 M2
c. Receiving RAAS-I for at least 4 weeks
d. Recently initiated on SGLT2-I
Exclusion Criteria
1.eGFR, calculated by CKD-EPI <30 mL/min/1.73 M2
2.Non-consenting patients
3.Doubt about the nature of kidney disease. Suspicion of nondiabetic renal disease such as renal artery stenosis, glomerular disease or other systemic disorders with renal involvement
4.Ongoing active infection, sepsis or symptomatic UTI, active malignancy
5.History of symptomatic UTI in the past 6 months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method